Literature DB >> 29750702

Morphologic Features of Gastric-type Cervical Adenocarcinoma in Small Surgical and Cytology Specimens.

Gulisa Turashvili1, Elizabeth G Morency, Mihaela Kracun, Deborah F DeLair, Sarah Chiang, Robert A Soslow, Kay J Park, Rajmohan Murali.   

Abstract

Gastric-type cervical adenocarcinoma (GCA) is a human papillomavirus-unassociated, aggressive, chemorefractory tumor. Well-differentiated examples may exhibit bland morphologic appearances, which could potentially lead to misdiagnosis, particularly in limited material. We sought to characterize the morphologic features of GCA in surgical biopsy and cytology specimens. We identified patients with histologic diagnoses of GCA or minimal-deviation adenocarcinoma between 2004 and 2017. Available slides from biopsy, curettage, and cytology specimens were reviewed. Fifty-nine specimens (37 histology, 22 cytology) were reviewed from 23 patients, including histology specimens alone from 6 patients, cytology specimens alone from 4 patients, and both types of specimen from 13 patients. The median patient age was 52 yr (range, 29-83 yr). Biopsies showed well-to-moderately differentiated adenocarcinomas composed of cells with pale or foamy cytoplasm and well-defined cytoplasmic borders. Nuclei exhibited mild-to-moderate pleomorphism with small nucleoli. The diagnosis was challenging in a minority of biopsies in which neoplastic glandular epithelium was scant, fragmented, and/or well differentiated. Cytology slides showed single and crowded clusters of tumor cells with pale, foamy, and/or vacuolated cytoplasm and well-defined cytoplasmic borders. Nuclei were moderately pleomorphic, round to oval with one or more nucleoli. Of 20 submitted biopsies, GCA was suspected by the submitting pathologist in only 5 (25%) cases. Awareness of the morphologic features and use of confirmatory ancillary studies (eg, immunohistochemistry for markers of gastric differentiation and human papillomavirus testing) will allow accurate diagnosis of these aggressive tumors in biopsy and cytology specimens.

Entities:  

Mesh:

Year:  2019        PMID: 29750702      PMCID: PMC6230321          DOI: 10.1097/PGP.0000000000000519

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  46 in total

1.  Lobular endocervical glandular hyperplasia represents pyloric gland metaplasia?

Authors:  K Ishii; H Ota; T Katsuyama
Journal:  Am J Surg Pathol       Date:  2000-02       Impact factor: 6.394

2.  Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma.

Authors:  E C Pirog; B Kleter; S Olgac; P Bobkiewicz; J Lindeman; W G Quint; R M Richart; C Isacson
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

3.  Immunohistochemical expression of gastric mucin and p53 in minimal deviation adenocarcinoma of the uterine cervix.

Authors:  T Ichimura; T Koizumi; H Tateiwa; S Yamaguchi; M Takemori; K Hasegawa; R Nishimura
Journal:  Int J Gynecol Pathol       Date:  2001-07       Impact factor: 2.762

4.  Lobular endocervical glandular hyperplasia is a metaplastic process with a pyloric gland phenotype.

Authors:  Y Mikami; S Hata; J Melamed; K Fujiwara; T Manabe
Journal:  Histopathology       Date:  2001-10       Impact factor: 5.087

5.  Cytologic and cytochemical features of adenoma malignum of the uterine cervix.

Authors:  K Ishii; T Katsuyama; H Ota; T Watanabe; I Matsuyama; S Tsuchiya; T Shiozawa; T Toki
Journal:  Cancer Cytopathol       Date:  1999-10-25       Impact factor: 5.284

6.  Lobular endocervical glandular hyperplasia, not otherwise specified: a clinicopathologic analysis of thirteen cases of a distinctive pseudoneoplastic lesion and comparison with fourteen cases of adenoma malignum.

Authors:  M R Nucci; P B Clement; R H Young
Journal:  Am J Surg Pathol       Date:  1999-08       Impact factor: 6.394

7.  The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study.

Authors:  H O Smith; M F Tiffany; C R Qualls; C R Key
Journal:  Gynecol Oncol       Date:  2000-08       Impact factor: 5.482

8.  Reappraisal of orthodox histochemistry for the diagnosis of minimal deviation adenocarcinoma of the cervix.

Authors:  I Hayashi; H Tsuda; T Shimoda
Journal:  Am J Surg Pathol       Date:  2000-04       Impact factor: 6.394

Review 9.  Endocervical adenocarcinoma and its variants: their morphology and differential diagnosis.

Authors:  R H Young; P B Clement
Journal:  Histopathology       Date:  2002-09       Impact factor: 5.087

10.  The role of human papillomavirus in cervical adenocarcinoma carcinogenesis.

Authors:  S Andersson; E Rylander; B Larsson; A Strand; C Silfversvärd; E Wilander
Journal:  Eur J Cancer       Date:  2001-01       Impact factor: 9.162

View more
  4 in total

1.  Massively parallel sequencing analysis of 68 gastric-type cervical adenocarcinomas reveals mutations in cell cycle-related genes and potentially targetable mutations.

Authors:  Pier Selenica; Barbara Alemar; Cathleen Matrai; Karen L Talia; Emanuela Veras; Yaser Hussein; Esther Oliva; Regina G H Beets-Tan; Yoshiki Mikami; W Glenn McCluggage; Takako Kiyokawa; Britta Weigelt; Kay J Park; Rajmohan Murali
Journal:  Mod Pathol       Date:  2020-12-14       Impact factor: 8.209

Review 2.  HPV-Negative Cervical Cancer: A Narrative Review.

Authors:  Francesca Arezzo; Gennaro Cormio; Vera Loizzi; Gerardo Cazzato; Viviana Cataldo; Claudio Lombardi; Giuseppe Ingravallo; Leonardo Resta; Ettore Cicinelli
Journal:  Diagnostics (Basel)       Date:  2021-05-26

3.  Secondary Involvement of the Uterine Cervix by Nongynecologic Neoplasms: A Detailed Clinicopathologic Analysis.

Authors:  Gulisa Turashvili; Wesley R Samore; Esther Oliva; Olga Ioffe; Robert Riddell; Kay J Park; Lars-Christian Horn
Journal:  Am J Surg Pathol       Date:  2020-12       Impact factor: 6.298

4.  A retrospective study on incidence, diagnosis, and clinical outcome of gastric-type endocervical adenocarcinoma in a single institution.

Authors:  Anna Radomska; Daniel Lee; Heather Neufeld; Nancy Korte; Emina Torlakovic; Anita Agrawal; Rajni Chibbar
Journal:  Diagn Pathol       Date:  2021-07-31       Impact factor: 2.644

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.